EpilepsyMeds receives Highly Commended recognition at Excellence in Healthcare Partnership Awards 2026
February 17, 2026 | Digital pharma, EHP Awards, Epilepsy, apps
EpilepsyMeds received Highly Commended recognition at the Excellence in Healthcare Partnership Awards 2026, celebrating the collaboration between Desitin Pharma, ChangeMed and Genetic Digital in advancing epilepsy care.
EpilepsyMeds, a digital clinical decision-support app developed through a partnership between Desitin Pharma, ChangeMed and Genetic Digital, has received a Highly Commended award at the Excellence in Healthcare Partnership Awards 2026.
The recognition highlights the strength of the collaboration and the real-world impact of the project in supporting safer, more confident clinical decision-making in epilepsy care.
EpilepsyMeds was developed in response to insights from multidisciplinary advisory boards, which identified a genuine challenge faced by healthcare professionals: the difficulty of quickly comparing anti-seizure medicines by formulation, excipients and patient-specific considerations at the point of care. These insights directly shaped the design and functionality of the app, ensuring it addressed an everyday clinical need rather than a theoretical use case.
The mobile-first tool provides healthcare professionals with fast, reliable access to licensed anti-seizure medicines information, including formulation details, excipient content and direct links to SmPCs. It is designed to support prescribing decisions in complex settings such as paediatrics, dysphagia, ketogenic diet management and polytherapy.
The project brought together Desitin Pharma’s pharmaceutical and regulatory leadership, ChangeMed’s clinical and academic expertise, and Genetic Digital’s digital product design and development capabilities. The partnership model ensured strong governance, clinical accuracy and usability throughout development.
Speaking following the awards ceremony, representatives from the partnership said the recognition reflects the value of co-creating digital solutions grounded in real-world clinical insight and close collaboration across industry, academia and digital health.
The Excellence in Healthcare Partnership Awards celebrate best practice in collaborative working across healthcare and the life sciences, recognising projects that deliver tangible benefit for patients, clinicians and the wider health system.
The awards ceremony took place in London on 5 February 2026.
Genetic Digital is a pharma digital agency focused on delivering compliant, patient and HCP-centred digital solutions for pharmaceutical and life sciences organisations.
This content was provided by Genetic Digital
Company Details
Latest Content from Genetic Digital
EpilepsyMeds receives Highly Commended recognition at Excellence in Healthcare Partnership Awards 2026
EpilepsyMeds received Highly Commended recognition at the Excellence in Healthcare Partnership Awards 2026, celebrating the collaboration between Desitin Pharma, ChangeMed and Genetic Digital in advancing epilepsy care.
Genetic Digital Wins Silver at PM Society Digital Awards for Epilepsy Meds Clinical Support App
Genetic Digital wins Silver at the PM Society Digital Awards for Epilepsy Meds, a clinical support app developed with Desitin and ChangeMed to aid patient-specific prescribing in epilepsy care.
Genetic Digital Shortlisted for PM Society Digital Award for Epilepsy Meds App
Genetic Digital has been shortlisted for a PM Society Digital Award for Epilepsy Meds, a mobile-first app that helps healthcare professionals make safer, patient-specific prescribing decisions in epilepsy care. The...
Smarter, Compliant Engagement: Why Pharma is Warming Up to Chat-Based Solutions
Pharma marketers are embracing chat-based tools to engage HCPs and patients faster, simplify PI sharing, and gain real-time insights — all while staying ABPI and GDPR compliant. When aligned with...
Why Pharma’s Digital PI Compliance Problem Needs a Cross-Functional Fix
In many pharma teams, the responsibility for keeping prescribing information (PI) up to date online falls into a grey area. > Regulatory signs it off. > Marketing publishes it. >...
Web Design Strategies for Pharma & Life Sciences in 2025
As we approach 2025, healthcare and life sciences SMEs face an increasingly digital world. A seamless, mobile-friendly website that harnesses AI-driven personalisation and intuitive design elements isn’t just a luxury...
Leveraging the ABPI QR Code Update: Enhancing Prescribing Information Through Best Practices
ABPI's recent update permits QR codes in printed pharmaceutical materials for prescribing information. By ensuring visibility, providing clear instructions, linking directly, and keeping content current, companies can enhance accessibility, ensure...
Pi 360 – A Smarter, Automated Solution for Digital Prescribing Information (PI) & QR Code Compliance
Life sciences digital agency Genetic Digital has launched Pi 360, a cutting-edge web application designed to help pharmaceutical companies automate the creation, management and distribution of Prescribing Information (PI) while...
Hidden in Plain Sight: The Compliance Risks of Search Engine Indexed Pharma Content
Pharma companies must balance HCP access and MHRA/ABPI compliance by preventing public search indexing of promotional prescription medicine content.
Beyond the Pill: The Power of Pharma Companion Apps
Pharma companion apps are transforming healthcare by offering support beyond traditional treatments, enhancing patient engagement and outcomes. From medication reminders to symptom tracking, these apps provide valuable tools for both...